233 related articles for article (PubMed ID: 30827356)
1. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.
Shi Z; Zhang T; Long W; Wang X; Zhang X; Ling X; Ding H
Int J Gynecol Cancer; 2012 Sep; 22(7):1125-9. PubMed ID: 22801034
[TBL] [Abstract][Full Text] [Related]
5. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis between benign and malignant-transformed hydatidiform mole.
Ma L; Xiang Y; Zhao J; Feng F; Wan X
J Reprod Med; 2008 Aug; 53(8):623-8. PubMed ID: 18773628
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
[TBL] [Abstract][Full Text] [Related]
8. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of patients with lung metastasis of invasive mole before evacuation of hydatidiform mole].
Feng FZ; Xiang Y; Shan Y; Wan XR; Oang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):830-3. PubMed ID: 18476517
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R
Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789
[No Abstract] [Full Text] [Related]
11. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
12. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
13. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
14. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
15. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Neoplastic Transformation of Hydatidiform Mole: Current Evidence.
Laban M; El-Swaify ST; Refaat MA; Ibrahim EA; Abdelrahman RM
Reprod Sci; 2021 Oct; 28(10):3010-3012. PubMed ID: 34341951
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
